Lemaitre Vascular (LMAT) Short term Debt (2020 - 2021)

Lemaitre Vascular (LMAT) reported Short term Debt of $3.0 million for Q2 2021, down 88.0% year-over-year from $25.0 million in Q2 2020, and up 9.09% quarter-over-quarter from $2.8 million in Q1 2021.

Lemaitre Vascular (LMAT) Short term Debt (2020 - 2021) Analysis & Trends

Lemaitre Vascular (LMAT) has 2 years of Short term Debt data on file, last reported at $3.0 million in Q2 2021.

  • Short term Debt for Q2 2021 came in at $3.0 million, down 88.0% year-over-year; the trailing twelve-month figure through Jun 2021 was $3.0 million (down 88.0% YoY), and the FY2020 annual result was $2.5 million, changed N/A from the prior year.
  • Short term Debt improved to $3.0 million in Q2 2021 per LMAT's latest filing, from $2.8 million in the prior quarter.
  • Over five years, Short term Debt peaked at $25.0 million in Q2 2020 and troughed at $2.5 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Lemaitre Vascular 2.12 Bn 1.75 Bn 48.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2021 3.00 Mn
Mar 31, 2021 2.75 Mn
Dec 31, 2020 2.50 Mn
Sep 30, 2020 21.00 Mn
Jun 30, 2020 25.00 Mn